Eurogentec at "DATS"

As a GMP-focused CDMO specializing in therapeutic oligonucleotides, Eurogentec supports biopharmaceutical innovators from early discovery through to commercial manufacturing. Throughout DATS, our experts will be available to exchange on the latest advances in antisense and RNA-based therapeutics, and to share insights on process development, GMP manufacturing, and scale-up strategies.

Meet our team to discuss your oligonucleotide projects, explore tailored solutions, and gain expert guidance to help accelerate the development of next-generation nucleic acid therapeutics.

Learn more about our oligonucleotide services:

Therapeutic Oligos       

About the event :

The Dutch Antisense Therapeutics Symposium (DATS) is a premier industry event bringing together key stakeholders from across the oligonucleotide and RNA therapeutics landscape. The symposium provides a unique forum for scientists, biotech innovators, pharmaceutical companies, technology providers, and regulatory experts to exchange insights on the latest advances in antisense and RNA-based drug development.

Covering topics from discovery and delivery technologies to clinical development, manufacturing, and regulatory pathways, DATS highlights the innovations shaping the future of precision medicine. The event also offers valuable networking opportunities, fostering collaborations that help accelerate the development of next-generation nucleic acid therapeutics.

Discover the agenda and register on the DATS website. 

Book a meeting with our team today :

Muriel CRAYNEST

Business Development Manager Therapeutics

Thierry WALSCHAERTS

Sales Development Manager Genomics

Don't miss this opportunity to talk with our experts, schedule a meeting today to avoid the line. See you there!

Appointment request